<DOC>
	<DOCNO>NCT01002443</DOCNO>
	<brief_summary>Helicobacter pylorus ( H. pylorus ) associate gastric cancer epidemiological studies.Gastric atrophy intestinal metaplasia cause H. pylorus consider precancerous lesion , whether H. pylorus eradication improve lesion controversial.The primary objective study evaluate whether Helicobacter pylorus eradication improve glandular atrophy intestinal metaplasia know precancerous condition patient undergoing subtotal gastrectomy gastric cancer .</brief_summary>
	<brief_title>Efficacy Study Helicobacter Pylori Eradication Patients Undergoing Subtotal Gastrectomy Gastric Cancer</brief_title>
	<detailed_description>Helicobacter pylorus ( H. pylorus ) primary etiological agent lead chronic gastritis peptic ulcer . The organism also associate gastric cancer epidemiological study . However , detail mechanism carcinogenesis remain unknown . Histolopathological study indicate chronic H. pylorus infection progress decade stage chronic gastritis , atrophy , intestinal metaplasia , dysplasia cancer . Gastric atrophy intestinal metaplasia consider precancerous lesion , whether H. pylorus eradication improve lesion controversial . And issue evaluate gastric cancer patient . However , despite lack evidence proven well-designed study , current guideline Europe Japan recommend H. pylori eradication treatment patient treat gastric cancer surgically endoscopically . Thus , important evaluate whether H. pylorus eradication improve know precancerous lesion , i.e . glandular atrophy intestinal metaplasia gastric cancer patient . Such histological improvement may eventually reduce secondary gastric cancer development provide evidence current guideline . Helicobacter pylori primary etiological agent lead chronic gastritis peptic ulcer . The organism also associate gastric cancer epidemiological study . However , detail mechanism carcinogenesis remain unknown . Histolopathological study indicate chronic H. pylorus infection progress decade stage chronic gastritis , atrophy , intestinal metaplasia , dysplasia cancer . Gastric atrophy intestinal metaplasia consider precancerous lesion , whether H. pylorus eradication improve lesion controversial . And issue evaluate gastric cancer patient . However , despite lack evidence proven well-designed study , current guideline Europe Japan recommend H. pylori eradication treatment patient treat gastric cancer surgically endoscopically . Thus , important evaluate whether H. pylorus eradication improve know precancerous lesion , i.e . glandular atrophy intestinal metaplasia gastric cancer patient . Such histological improvement may eventually reduce secondary gastric cancer development provide evidence current guideline .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>AGC EGC confirm endoscopy Histologically confirm adenocarcinoma stomach Helicobacter pylori infection confirm biopsy CLO Pre op CT stage : IA , IB , II , IIIA accord UICC TNM classification system Pre op biopsy ( body LC side ) show either intestinal metaplasia glandular atrophy ( least grade 1 ) Tumor location suitable subtotal gastrectomy i.e . distal low body Informed consent sign Recurrent gastric cancer Previous serious side effect antibiotic H. pylori eradication treatment history Other malignancy within past 5 year Pregnant nursing woman Serious concurrent infection nonmalignant disease liver cirrhosis , renal failure , cardiovascular disease Psychiatric disorder would preclude compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>glandular atrophy</keyword>
	<keyword>intestinal metaplasia</keyword>
	<keyword>subtotal gastrectomy</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>Precancerous lesion gastric cancer</keyword>
</DOC>